COMPARE · Reviewed August 3, 2026
BTSG vs HQY
Verdict: Side-by-side breakdown using the Bull Rankings model. BTSG scored 56.8, HQY scored 67.6 — HQY leads.
Compare another set
BTSG
BrightSpring Health Services, Inc.
56.8
$63.13 · $12.5B
fundamentals as of
Score gap
10.8
HQY leads
HQY
HealthEquity, Inc.
67.6
$104.45 · $8.7B
fundamentals as of
The model, pillar by pillar (0–100 each)
BTSG
stronger →← stronger
HQY
51
Qualityreturns · margins · balance sheet
70
100
Growthrevenue & earnings expansion
69
36
Valuevaluation vs sector peers
64
HQY is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
BTSG
HQY
$402mC
FCF
$488mC
+26.4%A-
Rev
+7.6%B
1.16C
D/E
0.48B
56.4xC
P/E
39.1xC+
1.92C+
PEG
1.44B
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
Valuation · DCF cross-check
BTSG
HQY
129% above
Price vs fair valuelower is cheaper
7% below
~39%/yr
Growth the price implies10-yr FCF · lower = less priced in
~8%/yr
-66%
1-yr DCF upside
-8%
-56%
5-yr DCF upside
+8%
-38%
10-yr DCF upside
+35%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
BTSG
Why this score
- Diluting shareholders
- Short track record
HQY
Why this score
- Buying back stock
The companies
BTSGBrightSpring Health Services, Inc.
Why now
Health Information Services · market cap $12.5b. 14% off the 52-week high of $73.75. Revenue growing +26% — in hypergrowth territory. 17 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $78.53 (implying +24% upside).
Moat
ROE 18% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 110% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Trailing P/E 56.4x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Beta 1.88 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return. Net margin 2.5% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
HQYHealthEquity, Inc.
Why now
Health Information Services · market cap $8.7b. Trading near 52-week high of $105.96 — momentum setup, limited technical margin of safety. 15 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $118.53 (implying +13% upside).
Moat
Net margin 17% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 11% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Trading within 1% of the 52-week high — limited technical margin of safety; a momentum reversal would test conviction. Trailing P/E 39x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.